Clinical Trial Update: Trifecta Research Study [Phase 2]

View source ↗

Summary

Johns Hopkins University's Phase 2 clinical trial was withdrawn from the registry. The withdrawal applies to conditions including post-traumatic stress disorder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder
• Traumatic Brain Injury

Snippet

Sponsor: Johns Hopkins University | Conditions: PTSD - Post Traumatic Stress Disorder, Cognitive Dysfunction | Phase 2 | Status: WITHDRAWN